TIDMFDBK
RNS Number : 1183K
Feedback PLC
20 April 2020
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulation (EU) No. 596/2014 ("MAR").
Feedback plc
Bleepa (R) rolled-out across Pennine Acute Hospitals NHS Trust to help manage the COVID-19 peak
-- Pennine Acute Hospitals NHS Trust rolls-out Bleepa (R) the
secure medical imaging based communication platform to help manage
the COVID-19 workflow
-- Team to team referrals of COVID-19 cases to be managed
through Bleepa (R) to ensure rapid clinical assessment
-- Bleepa (R) to support COVID-19 clinical research study, the Recovery Trial
London, 20 April 2020: Feedback Medical Ltd, a wholly-owned
subsidiary of Feedback plc (AIM: FDBK, "Feedback" or the
"Company"), the specialist medical imaging technology company,
today announces that Bleepa (R) , Feedback's flagship imaging-based
communication platform, will be rolled-out across the Pennine Acute
Hospitals NHS Trust with immediate effect as a key patient
management tool to assist its coronavirus response.
As the NHS meets the challenge of COVID-19, critical medical
imaging studies are increasingly vital, with chest X-rays and CT
scans being key aids. As a pioneering Trust and GDE Fast Follower
site, Pennine Acute Hospitals NHS Trust has looked at innovative
digital solutions to support greater collaboration and
communication amongst clinical staff on the front-line and have
recognised Bleepa (R) as being a key asset in their response to
this outbreak.
The Trust is already familiar with the Bleepa (R) technology
having piloted the technology for many months within the
Respiratory inpatient referral pathway. The feedback from the pilot
has been used to hone the tool and enable an improved version of
Bleepa (R) to have been developed which is now being deployed to
assist the Trust in delivering its COVID-19 response.
New features were developed at pace within a two week period by
the Feedback team, and their development partners Future Processing
and include a smart form for clinical data entry, group transfer
and the ability to designate patients with a clinical status such
as ventilation status. These features enable Coronavirus cases to
be tracked as they move through the clinical pathways and more
easily enable team to team referral.
Around 200 frontline clinicians within the Acute Medical Team
have now been enrolled on Bleepa (R) with more anticipated in the
coming week.
The unique features of the app will facilitate key decision
processes within the Trust's COVID-19 workflow by connecting
clinical decision makers with frontline personnel and making
relevant imaging available at the push of a button. Bleepa (R) will
capture the clinical dialogue and decision making processes,
subsequently forming part of the patient record after the admission
is completed.
In addition to supporting clinical delivery Bleepa (R) will
facilitate a clinical research trial being run by the Trust. The
Recovery Trial is being conducted by a dedicated team of Research
Nurses within the Trust and will seek to assess the recovery
pathway of different patient groups from COVID-19.
Tom Oakley, CEO of Feedback plc, said:
"Pennine have been instrumental in the development and evolution
of Bleepa (R) and it is very rewarding to now put what we have
developed to use in assisting the Trust at a time of great need. It
will become increasingly important for clinicians to have timely
access to medical imaging and other team members especially in
light of a growing requirement for remote access due to self
isolation. Bleepa (R) is the only imaging communication tool that
can deliver the required workflow support at the scale required and
it's not just Radiologists who need access to imaging now but all
frontline personnel. The whole Company feels deeply privileged to
be able to help and we are immensely proud to see our tool deployed
and already making a difference to delivery at this time. We will
work hard to ensure that Bleepa (R) can support and protect as many
frontline NHS staff as possible and we are already looking to
support other NHS Trusts who would similarly benefit from our
system."
Georges Ng Man Kwong, Consultant Chest Physician (Oldham Care
Organisation) and CCIO (Pennine Acute NHS Trust, part of Northern
Care Alliance), said:
"After an initial pre-Covid pilot study Bleepa(R) was identified
as a potential secure solution to register and identify patients
suitable for the RECOVERY trial ( a national randomised study
looking at novel Covid treatments) and as a messaging application
to support (multi-speciality) clinical decision making. It has
rapidly been adopted by our research nurses and clinician
specialists in key acute areas across the hospital providing
additional opportunities to identify and track patients receiving
respiratory and palliative care respectively. The extraordinary
circumstances within the NHS during the Coronavirus pandemic has
enabled us to test and modify the Bleepa(R) solution at pace and
go-live within only a few weeks with satisfactory clinical and
technical specifications. Our on-going engagement with Bleepa(R)
continues to identify additional specialties and scope to widen
its' application within our health-care organisation that will aid
clinicians both during this challenging period and once the
pandemic crisis has ended."
Bleepa (R) is a secure image-based communication platform which
provides access to clinical grade medical images and facilitates
instant messaging based case discussion through a zero footprint
application. Bleepa (R) can be accessed from any internet connected
device including phones, tablets, laptops and desktops; clinicians
can use their own devices and therefore no additional hardware is
required.
Any medical imaging investigation can be seamlessly shared
through Bleepa (R) to the entire clinical team, even if those teams
are geographically separated or having to work remotely. Cases can
be discussed through secure instant messaging and image annotation,
allowing comments and decisions to be communicated instantly
between team members. Importantly, during the outbreak, Bleepa (R)
can enable case review by clinicians at other hospitals where
multisite communication is needed.
Home-based image review and case discussion at this scale
requires a new infrastructure and a secure bespoke imaging solution
which is capable of scaling to meet these demands. Bleepa (R) is
designed for exactly this purpose and overcomes the problems
associated with trying to scale traditional VPN-based remote access
solutions to hospital software.
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited (Joint
Broker)
Patrick Claridge / John Howes +44 (0)20 3815 8880
Instinctif Partners +44 (0)20 7457 2020
Melanie Toyne-Sewell / Phillip Marriage +44 (0)7890 022 814
feedbackplc@instinctif.com
Notes to editors
About Feedback plc - www.fbk.com
Feedback plc (AIM: FDBK) is a specialist medical imaging
technology company providing innovative software and systems,
through its fully-owned trading subsidiary, Feedback Medical
Limited. Its products advance the work of radiologists, clinicians
and medical researchers by improving workflows and giving unique
insights into diseases, particularly cancer.
Feedback has launched Bleepa , a new secure, encrypted medical
communication app for clinicians accessible through smartphones,
tablets and desktops that facilitates rapid clinical messaging and
review of medical grade imaging for all members of a clinical team,
directly from a hospital Picture Archiving and Communications
System (PACS). For more information on Bleepa , see www.bleepa.com
.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCILMBTMTTBTFM
(END) Dow Jones Newswires
April 20, 2020 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024